Laves-Arzneimittel GmbH

Name: Laves-Arzneimittel GmbH
Telephone: +41 41 984 05 00

Swiss Biotech Association

Member

Laves-Arzneimittel GmbH has focused on the exploration and development of preparations based on the probiotic Escherichia coli strain Laves discovered in 1931 by Dr. Wolfgang Laves.

http://www.laves-pharma.de
+41 41 984 05 00
info@laves-pharma.ch
Viktor Helbing

Location

Lavesstrasse, 6247 Schötz, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

1908
Number of employees in Switzerland

10-19

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Praed Pharmaceuticals Ltd

Praed Pharmaceuticals is biopharmaceutical company founded by industry experts. Our mission is to deliver a next generation treatment for Crohn’s disease. We are developing a promising oral compound, cadazolid, for the treatment of Crohn’s disease.
4054 Basel

Member

Philip Morris International

https://www.pmi.com/our-transformation
2000 Neuchâtel

Member

Ymmunobio AG

Ymmunobio AG is a preclinical stage biotechnology company developing a novel class of immune oncology therapeutic antibodies. The proprietary CEACAM1 antibodies are having a direct co-stimulatory effect on immune cells in addition to interfering with the CEACAM1-CEACAM mediated check-point blockade.
4125 Riehen

Member